Since NAC protocols allow for the monitoring of responses to chemotherapy in a carefully controlled manner by analyzing the pathologic response, we investigated whether ALDH1 expression could serve as a useful biomarker in breast cancer treated with chemotherapy. Here, ALDH1A1 is linked to breast carcinoma.